Differentially expressed genes following Mod knockdown. by Amalia S. Parra (4173004)

Subjects:

RNA targets of Mod identified by RiP-Seq. by Amalia S. Parra (4173004)

Subjects:

Loss of Mod causes cell cycle defects. by Amalia S. Parra (4173004)

Subjects:

Mod antibody and RNAi validations. by Amalia S. Parra (4173004)

Subjects:

Mod is required to maintain nucleolar architecture. by Amalia S. Parra (4173004)

Subjects:

Differential gene expression analysis following Mod knockdown. by Amalia S. Parra (4173004)

Subjects:

Mod loss is associated with a reduction of central brain NBs. by Amalia S. Parra (4173004)

Subjects:

RNA targets and biological process GO terms associated with Mod RiP-Seq analysis. by Amalia S. Parra (4173004)

Subjects:

Mod localizes both within and outside the nucleolus in NBs. by Amalia S. Parra (4173004)

Subjects:

Test factor coding. by Xueting Ma (390540)

Subjects:

HSP90 inhibition by RGRN-305 decreased the gene expression of proinflammatory cytokines induced by SARS-CoV-2 S protein. by Hakim Ben Abdallah (14578241)

Multivariate logistic regression analysis on the risk factors associated with prolonged APTT. by Huan Wang (109286)

Subjects:

Seasonal spatial-temporal trend of NDVI in burned areas across Africa (2001–2020). Percentages (%) of increases or decreases (%) based on the Mann-Kendall test and statistically significant (<i>p</i> < 0.05) and non-significant (p > 0.05) values. by Oswaldo Maillard (20660661)

KEGG pathway enrichment analysis of lactoferrin and Coenzyme Q10 in sarcopenia. by Wenbin Wu (292223)

Subjects:

BA attenuated the decrease in the integrity and increase in the permeability of the epithelial barrier injury induced by LPS in Caco2 cell monolayers. by Luqiong Liu (11537092)

Transcriptome sequencing enriched sarcopenia related GO Biological process (BP) and Molecular function (MF). Enriched GO BP of DEGs. by Wenbin Wu (292223)

Subjects:

Statistically significant linear increase in use of antidementia medications and antipsychotics during the observed time period. by Jelena Filimonovic (22305307)

Subjects:

Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia... by Mingee Choi (15250732)

Subjects:

Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019). by Mingee Choi (15250732)

Subjects:

Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later. by Mingee Choi (15250732)

Subjects: